Impact of perceived contraceptive policy changes on long acting reversible contraception dispensing trends.


Journal

The European journal of contraception & reproductive health care : the official journal of the European Society of Contraception
ISSN: 1473-0782
Titre abrégé: Eur J Contracept Reprod Health Care
Pays: England
ID NLM: 9712127

Informations de publication

Date de publication:
Feb 2021
Historique:
pubmed: 18 11 2020
medline: 26 10 2021
entrez: 17 11 2020
Statut: ppublish

Résumé

We observed the long-term trend of Long Acting Reversible Contraception (LARC) usage before and after the 2016 presidential election. We observed the rate of LARC dispensed at a university student health centre in the 18 months preceding and 27 months following the 2016 U.S. presidential election which posed threat to contraception access. We applied a segmented regression model using two linear regression line segments to evaluate whether there is a time point where the trend of LARC dispensing changed. We fit the regression models with a breakpoint at month 0 (election month) and 3 months with a Locally Estimated Scatterplot Smoothing (LOESS) estimate with parameters obtained by estimating simple linear regression models separately below and above the breakpoint '0'. There were a total of 2067 LARC methods dispensed from May 2015 to February 2019. The average number of LARC methods dispensed before November 2016 was 38/month and increased to 51/month post-presidential election. The LARC dispense rate significantly increased each month (0.38, 1.74; 95% confidence level, Our study is the first to report long-term trends (27 months post-election) in LARC uptake amidst the public discourse that suggested the end of a policy that provided LARC insurance coverage. Although this observational study cannot suggest causality, the findings could reflect actions taken to prevent unintended pregnancy in response to the event of uncertain national policy.

Identifiants

pubmed: 33198521
doi: 10.1080/13625187.2020.1837767
doi:

Substances chimiques

Contraceptive Agents, Female 0

Types de publication

Journal Article Observational Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

58-61

Auteurs

Aparna Sridhar (A)

Department of Obstetrics and Gynecology, University of California Los Angeles, Los Angeles, CA, USA.
University of California Los Angeles Arthur Ashe Student Health & Wellness Center, Los Angeles, CA, USA.

Sarah R Friedman (SR)

Department of Urology, University of California Los Angeles, Los Angeles, CA, USA.

Myung-Shin K Sim (MK)

University of California Los Angeles General Internal Medicine & Health Services Research, Los Angeles, CA, USA.

William Troung (W)

University of California Los Angeles Arthur Ashe Student Health & Wellness Center, Los Angeles, CA, USA.

Sam Elias (S)

University of California Los Angeles Arthur Ashe Student Health & Wellness Center, Los Angeles, CA, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH